about
Structural and functional analysis of horse cathelicidin peptides.LL-37 protects rats against lethal sepsis caused by gram-negative bacteriaThe human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.Modulation of cytokine gene expression by cathelicidin BMAP-28 in LPS-stimulated and -unstimulated macrophages.Evaluation of free or anchored antimicrobial peptides as candidates for the prevention of orthopaedic device-related infections.Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils.RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells.Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.Role of Cathelicidin Peptides in Bovine Host Defense and Healing.In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides.The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs.Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection.Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide.Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes.SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytesProduction of a recombinant antimicrobial peptide in transgenic plants using a modified VMA intein expression systemComparative activity and mechanism of action of three types of bovine antimicrobial peptides against pathogenic Prototheca sppA Rapid Fluorescence-Based Microplate Assay to Investigate the Interaction of Membrane Active Antimicrobial Peptides with Whole Gram-Positive BacteriaCovalent grafting of titanium with a cathelicidin peptide produces an osteoblast compatible surface with antistaphylococcal activity
P50
Q33981585-5AC7BAE1-C82D-4DDA-96DA-9EF89656384BQ34648782-15B3BD78-5B5D-49A5-B4A9-BDE12E012335Q37142680-46915936-A52F-4715-80D2-DA402B327EB4Q38732599-7CCEE2B8-4A24-4AB2-9522-8DEBF31D5E84Q39399662-A8809315-A649-4572-818F-692B06A13B2CQ40134888-E7F2090A-91D4-4983-BBB0-64DA5C8762CFQ40164583-74865387-D975-4A51-992A-FD3586546703Q40243056-F7404CBA-44A9-4E91-911C-5BE4E6D89183Q41074588-4E7692FC-4506-4C66-904C-206E5B05EF37Q42808621-20DF526B-073D-4C0E-8D90-2D8A88B50691Q43506522-9F4CF918-0D52-411A-A79A-245501A83DCEQ44158855-78CC88F5-2B73-4FDE-A5BA-C38C02D802E6Q44374419-B532A25E-FFD7-4EEE-98AB-E885B7C33953Q45187469-CBE89928-0F4E-4D9C-B343-E0FB32ADD435Q46631559-31B264BC-955D-4F2B-A1AE-76C893F012E0Q46662026-8A0C94D6-09C1-48CA-A20B-A971A426E925Q47956749-29114FF8-344A-44BD-877F-FED784C241F4Q50094911-D9EF3B7F-0654-4A25-BE43-A2FB9274C97FQ51224082-2AF13BF8-C61A-48FE-BDD6-DC7A4821D72AQ53920755-5FD991E2-60CA-4E50-AF14-1B25C8652A99Q54462332-E3618747-4FB6-469F-8DFF-53A9C45BCB87Q54640376-C3054D82-77DE-442D-84FF-64FD6E2A13AFQ57275277-EC46C1C7-CF66-4EAA-9212-3B0DD755F253Q74144121-55A1BA11-A249-4FA7-9F83-9403FAAEC3EBQ82506456-3A23793A-2AEE-46CB-B106-C92A48D5A496Q89861116-6AF1F76F-02D0-40F8-BBB0-71541EB45910Q90908220-1E6761B3-7F6F-46D4-AAC3-69784398E823
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Barbara Skerlavaj
@ast
Barbara Skerlavaj
@en
Barbara Skerlavaj
@es
Barbara Skerlavaj
@nl
type
label
Barbara Skerlavaj
@ast
Barbara Skerlavaj
@en
Barbara Skerlavaj
@es
Barbara Skerlavaj
@nl
prefLabel
Barbara Skerlavaj
@ast
Barbara Skerlavaj
@en
Barbara Skerlavaj
@es
Barbara Skerlavaj
@nl
P106
P21
P31
P496
0000-0003-0437-802X